24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Medical Disorders
Resources
Basic InformationLookupsLatest News
Virtual Doc Visits Suffice for Many With Neurological DisordersBPA Levels in Humans Are Underestimated: StudyCleaner Air Quickly Brings Big Health Benefits, Study FindsAll 50 States Now Reporting Cases of Severe Vaping-Linked Lung Injury3 Drugs for Severe Epileptic Seizures Are Equally Effective: StudyStudy Casts Doubt on Use of Common Heart Failure Drugs'Mobile Stroke Units' Help Rush Treatment to PatientsDistracted by Their Smartphones, Pedestrians Are Landing in the ERVaping May Have Triggered Lung Illness Typically Only Seen in MetalworkersMore Than 100 E. Coli Illnesses Now Linked to Romaine LettuceLow-Dose Aspirin Might Cut Cancer Risk, Especially for Overweight PeopleEspecially in the Young, Cholesterol Is No Friend to the HeartAre E-Scooters a Quick Ticket to the ER?Uncontrolled Asthma a Danger to Pregnant Women, BabiesHealth Tip: Common Causes of Knee PainSome Cities' Smog Can Ruin Your VacationParkinson's Treatment Has Unexpected Side EffectHeart Attack at 44 Helped Her Realize Diabetes' DangersCleaner Teeth, Healthier Heart?Obesity Might Weaken Some Drugs' Effectiveness Against AFibHow to Prevent Holiday HeadachesAir Pollution May Up Glaucoma RiskHealth Tip: Causes of Stomach UlcersHealth Tip: Treating ShinglesLeg Pain Could Spell Peripheral Artery Disease for SomeEven in Small Doses, Air Pollution Harms Older AmericansDon't Let Allergies Spoil Your HolidaysGot Chronic Heartburn? Easy Does It During the Thanksgiving FeastAHA News: Flu Prevention Strategies Beyond Getting a Shot and Washing Your HandsUltrasound Treatment Might Ease Parkinson's TremorsPopular Heartburn Drugs May Up Odds of Stomach BugGunshot Wounds Have Long-Term Health Consequences: StudyU.S. Poison Centers Field More Calls About Psychoactive Substances: StudyMore E. coli Illnesses Linked to Tainted Romaine LettuceFDA Approves First System to Insert Ear Tubes Under Local AnesthesiaFDA Approves Oxbryta for Treatment of Sickle Cell DiseaseWhere 'Superbugs' Lurk in Your Home - and How to Stop ThemPlay It Safe With Holiday FoodsCaffeine, Cough Medicines: What's in the Average Blood TransfusionVitamin E Compound Likely Culprit Behind Vaping Lung Illnesses, Study FindsDramatic Rise in Eye Injuries From BB and Paintball GunsObesity May Change the Teen Brain, MRI Study ShowsDon't Eat Romaine Lettuce Grown in Salinas, Calif., Due to E. Coli: FDAMusic Career Might Bring Ringing in the EarsBacteria Could Be Weapon Against Mosquito-Borne DengueHealth Tip: Five Common First-Aid MythsInfants May Not Be as Immune to Measles as ThoughtDoctors Spot a New, Severe Lung Illness Tied to VapingAHA News: Obesity, Other Factors May Speed Up Brain AgingPackaged Caesar Salad Suspected as Possible Source in E. coli Outbreak
Questions and AnswersLinks
Related Topics

Diabetes

FDA Approves First Contact Lens That Slows Myopia Progression


HealthDay News
Updated: Nov 18th 2019

new article illustration

MONDAY, Nov. 18, 2019 (HealthDay News) -- MiSight, the first contact lens indicated to slow the progression of myopia in children ages 8 to 12 years, has been approved by the U.S. Food and Drug Administration, the agency announced Friday.

The single-use, disposable, soft contact lenses should be discarded after one-day use and are not intended to be worn overnight. They are indicated to correct and slow progression of myopia in children with healthy eyes, the FDA noted. Like a standard corrective lens, one part of the MiSight contact lens corrects the refractive error to improve distance vision. Concentric peripheral rings in the lens also focus part of the light in front of the retina to reduce the stimulus causing myopia progression.

The FDA approved MiSight based on data from a prospective clinical trial at four clinical sites and real-world evidence. Safety and effectiveness of MiSight were demonstrated in a three-year randomized, controlled clinical trial of 135 children ages 8 to 12 years old at the start of treatment with MiSight or a conventional soft contact lens. During the entire three years, children who wore MiSight lenses had less progression of myopia compared with those who wore conventional soft contact lenses. Researchers also found that children who wore MiSight lenses had less change in the axial length of the eyeball at each yearly checkup. No serious ocular adverse events were reported for any patients.

The FDA also reviewed real-world data from a retrospective analysis of medical records of 728 children aged 8 to 12 years old from seven community eye care clinics. Data showed a similar rate of corneal ulcer cases in children who wore MiSight as in adults who wear contact lenses daily.

Approval was granted to CooperVision.

More Information